FDA told Pinnacle Peptides its SARMs sold online are unapproved new drugs with serious safety risks.
What happened
FDA reviewed the company's website in November 2025 and found it selling products marketed as selective androgen receptor modulators (SARMs) — compounds promoted to build muscle and treat conditions like osteoporosis and cancer. FDA says the products are drugs intended for human use despite "FOR RESEARCH ONLY" labels, and that they have no approved drug application. FDA also cited safety concerns including life-threatening liver toxicity and increased risk of heart attack and stroke.
What FDA found
The company sells SARMs as drugs for human use without any FDA-approved application, which is illegal.
FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)Website claims that the products treat osteoporosis, cancer, muscle loss and other conditions show they are intended as drugs.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1); 21 CFR 201.128"For research only" and "not for human use" statements do not cancel out the website's claims of human benefit.
21 CFR 201.128The products are "new drugs" because they are not generally recognized as safe and effective for the uses described in their labeling.
FD&C Act section 201(p), 21 U.S.C. 321(p)Shipping these unapproved drugs across state lines is prohibited.
FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)
What FDA wants
FDA asks the company to write within fifteen working days describing the specific steps taken to fix the violations and prevent them from happening again, or to explain why it believes the products are lawful. If corrections cannot be finished in that time, the company must say why and give a completion date.
Who should pay attention
- online sellers of SARMs and "research only" peptides
- companies whose payment processors or web hosts serve such sellers
- consumers and athletes buying SARMs online
This is a summary. Read the original letter on fda.gov.